Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Katz

Showing results (531-540 of 727) with videos related to

Pageof 73
Sort By:
JOP : Journal of the Pancreas|March 10, 2006
Common bile duct injection as a novel method for establishing red fluorescent protein (RFP)-expressing human pancreatic cancer in nude miceKazuhiko Tsuji, Meng Yang, Ping Jiang, et al.
Human Pathology|October 22, 2013
Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinomaMaryam Zenali, Michael J Overman, Asif Rashid, et al.
International Journal of Cancer|May 11, 2018
Risk factors associated with gastroenteropancreatic neuroendocrine tumors in a cohort of 2.3 million Israeli adolescentsLior H Katz, Zohar Levi, Gilad Twig, et al.
Cancers|December 11, 2022
Ashkenazi Jewish and Other White <i>APC</i> I1307K Carriers Are at Higher Risk for Multiple CancersEsther Forkosh, Michael Bergel, Kathryn E Hatchell, et al.
Journal of Medicinal Chemistry|November 1, 1988
Structure-activity relationships among analogues of pemedolac, cis-1-ethyl-1,3,4,9-tetrahydro-4-(phenylmethyl)pyrano[3,4-b]indo le-1-a cetic acid, a potent analgesic agentD Mobilio, L G Humber, A H Katz, et al.
Journal of Medicinal Chemistry|September 29, 2006
Pyrazolidine-3,5-diones and 5-hydroxy-1H-pyrazol-3(2H)-ones, inhibitors of UDP-N-acetylenolpyruvyl glucosamine reductaseAdam M Gilbert, Amedeo Failli, Jay Shumsky, et al.
The Prostate|April 11, 2022
Novel forms of prostate cancer chemoresistance to successful androgen deprivation therapy demand new approaches: Rationale for targeting BET proteinsJoakin O Mori, Jordan S Shafran, Marija Stojanova, et al.
Clinical Transplantation|April 19, 2000
Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicityB D Kahan, K L Napoli, P A Kelly, et al.
Carcinogenesis|November 4, 2000
SULT1A1 catalyzes 2-methoxyestradiol sulfonation in MCF-7 breast cancer cellsB C Spink, B H Katz, M M Hussain, et al.
Plos One|July 4, 2008
Simplifying consent for HIV testing is associated with an increase in HIV testing and case detection in highest risk groups, San Francisco January 2003-June 2007Nicola M Zetola, Carlos G Grijalva, Sarah Gertler, et al.
Pageof 73

Showing results (531-540 of 727) with videos related to

Sort By:
Pageof 73
JOP : Journal of the Pancreas|March 10, 2006
Common bile duct injection as a novel method for establishing red fluorescent protein (RFP)-expressing human pancreatic cancer in nude miceKazuhiko Tsuji, Meng Yang, Ping Jiang, et al.
Human Pathology|October 22, 2013
Clinicopathologic features and prognosis of duodenal adenocarcinoma and comparison with ampullary and pancreatic ductal adenocarcinomaMaryam Zenali, Michael J Overman, Asif Rashid, et al.
International Journal of Cancer|May 11, 2018
Risk factors associated with gastroenteropancreatic neuroendocrine tumors in a cohort of 2.3 million Israeli adolescentsLior H Katz, Zohar Levi, Gilad Twig, et al.
Cancers|December 11, 2022
Ashkenazi Jewish and Other White <i>APC</i> I1307K Carriers Are at Higher Risk for Multiple CancersEsther Forkosh, Michael Bergel, Kathryn E Hatchell, et al.
Journal of Medicinal Chemistry|November 1, 1988
Structure-activity relationships among analogues of pemedolac, cis-1-ethyl-1,3,4,9-tetrahydro-4-(phenylmethyl)pyrano[3,4-b]indo le-1-a cetic acid, a potent analgesic agentD Mobilio, L G Humber, A H Katz, et al.
Journal of Medicinal Chemistry|September 29, 2006
Pyrazolidine-3,5-diones and 5-hydroxy-1H-pyrazol-3(2H)-ones, inhibitors of UDP-N-acetylenolpyruvyl glucosamine reductaseAdam M Gilbert, Amedeo Failli, Jay Shumsky, et al.
The Prostate|April 11, 2022
Novel forms of prostate cancer chemoresistance to successful androgen deprivation therapy demand new approaches: Rationale for targeting BET proteinsJoakin O Mori, Jordan S Shafran, Marija Stojanova, et al.
Clinical Transplantation|April 19, 2000
Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicityB D Kahan, K L Napoli, P A Kelly, et al.
Carcinogenesis|November 4, 2000
SULT1A1 catalyzes 2-methoxyestradiol sulfonation in MCF-7 breast cancer cellsB C Spink, B H Katz, M M Hussain, et al.
Plos One|July 4, 2008
Simplifying consent for HIV testing is associated with an increase in HIV testing and case detection in highest risk groups, San Francisco January 2003-June 2007Nicola M Zetola, Carlos G Grijalva, Sarah Gertler, et al.
Pageof 73